{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:31:28Z","timestamp":1792636288335,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11239-015-1317-0","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T18:38:47Z","timestamp":1452969527000},"page":"32-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":271,"title":["Guidance for the treatment of deep vein thrombosis and pulmonary embolism"],"prefix":"10.1007","volume":"41","author":[{"given":"Michael B.","family":"Streiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"issue":"2","key":"1317_CR1","first-page":"610","volume":"82","author":"FR Rosendaal","year":"1999","unstructured":"Rosendaal FR (1999) Risk factors for venous thrombotic disease. Thromb Haemost 82(2):610\u2013619","journal-title":"Thromb Haemost"},{"issue":"6","key":"1317_CR2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2141.2010.08206.x","volume":"149","author":"WM Lijfering","year":"2010","unstructured":"Lijfering WM, Rosendaal FR, Cannegieter SC (2010) Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol 149(6):824\u2013833","journal-title":"Br J Haematol"},{"issue":"9094","key":"1317_CR3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(97)08140-3","volume":"350","author":"PS Wells","year":"1997","unstructured":"Wells PS, Anderson DR, Bormanis J et al (1997) Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 350(9094):1795\u20131798","journal-title":"Lancet"},{"issue":"12","key":"1317_CR4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-129-12-199812150-00002","volume":"129","author":"PS Wells","year":"1998","unstructured":"Wells PS, Ginsberg JS, Anderson DR et al (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129(12):997\u20131005","journal-title":"Ann Intern Med"},{"issue":"19","key":"1317_CR5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/archinte.168.19.2131","volume":"168","author":"FA Klok","year":"2008","unstructured":"Klok FA, Mos IC, Nijkeuter M et al (2008) Simplification of the revised geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 168(19):2131\u20132136","journal-title":"Arch Intern Med"},{"issue":"8","key":"1317_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-140-8-200404200-00005","volume":"140","author":"PD Stein","year":"2004","unstructured":"Stein PD, Hull RD, Patel KC et al (2004) D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 140(8):589\u2013602","journal-title":"Ann Intern Med"},{"issue":"5","key":"1317_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.annemergmed.2004.03.018","volume":"44","author":"JA Kline","year":"2004","unstructured":"Kline JA, Webb WB et al (2004) Impact of a rapid rule-out protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban US emergency department. Ann Emerg Med 44(5):490\u2013502","journal-title":"Ann Emerg Med"},{"issue":"5","key":"1317_CR8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1538-7836.2008.02944.x","volume":"6","author":"JA Kline","year":"2008","unstructured":"Kline JA, Courtney DM, Kabrhel C et al (2008) Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 6(5):772\u2013780","journal-title":"J Thromb Haemost"},{"issue":"9","key":"1317_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/emermed-2012-201730","volume":"30","author":"B Singh","year":"2013","unstructured":"Singh B, Mommer SK, Erwin PJ et al (2013) Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism-revisited: a systematic review and meta-analysis. Emerg Med J 30(9):701\u2013706","journal-title":"Emerg Med J"},{"issue":"9","key":"1317_CR10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/M14-1772","volume":"163","author":"AS Raja","year":"2015","unstructured":"Raja AS, Greenberg JO, Qaseem A et al (2015) Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 163(9):701\u2013711","journal-title":"Ann Intern Med"},{"issue":"3","key":"1317_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra0907731","volume":"363","author":"G Agnelli","year":"2010","unstructured":"Agnelli G, Becattini C (2010) Acute pulmonary embolism. N Engl J Med 363(3):266\u2013274","journal-title":"N Engl J Med"},{"key":"1317_CR12","doi-asserted-by":"crossref","first-page":"g1340","DOI":"10.1136\/bmj.g1340","volume":"348","author":"GJ Geersing","year":"2014","unstructured":"Geersing GJ, Zuithoff NP, Kearon C et al (2014) Exclusion of deep vein thrombosis using the wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 348:g1340","journal-title":"BMJ"},{"issue":"11","key":"1317_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2014.2135","volume":"311","author":"M Righini","year":"2014","unstructured":"Righini M, Van Es J, Den Exter PL et al (2014) Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 311(11):1117\u20131124","journal-title":"JAMA"},{"issue":"43","key":"1317_CR14","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","volume":"35","author":"SV Konstantinides","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G et al (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033\u20133069","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"1317_CR15","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ et al (2012) American College of Chest Physicians. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e419S\u2013e494S","journal-title":"Chest"},{"issue":"5","key":"1317_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2141.2010.08406.x","volume":"151","author":"D Jimenez","year":"2010","unstructured":"Jimenez D, Aujesky D, Yusen RD (2010) Risk stratification of normotensive patients with acute symptomatic pulmonary embolism. Br J Haematol 151(5):415\u2013424","journal-title":"Br J Haematol"},{"issue":"20","key":"1317_CR17","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1161\/01.CIR.0000147612.59751.4C","volume":"110","author":"UJ Schoepf","year":"2004","unstructured":"Schoepf UJ, Kucher N, Kipfmueller F et al (2004) Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 110(20):3276\u20133280","journal-title":"Circulation"},{"issue":"10","key":"1317_CR18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.12393","volume":"11","author":"J Trujillo-Santos","year":"2013","unstructured":"Trujillo-Santos J, den Exter PL, Gomez V et al (2013) Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost 11(10):1823\u20131832","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1317_CR19","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/cc10119","volume":"15","author":"G Coutance","year":"2011","unstructured":"Coutance G, Cauderlier E, Ehtisham J et al (2011) The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 15(2):R103","journal-title":"Crit Care"},{"issue":"9785","key":"1317_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","volume":"378","author":"D Aujesky","year":"2011","unstructured":"Aujesky D, Roy PM, Verschuren F et al (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378(9785):41\u201348","journal-title":"Lancet"},{"issue":"1","key":"1317_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1160\/TH12-07-0466","volume":"109","author":"W Zondag","year":"2013","unstructured":"Zondag W, den Exter PL, Crobach MJ, Hestia Study Investigators et al (2013) Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 109(1):47\u201352","journal-title":"Thromb Haemost"},{"issue":"6","key":"1317_CR22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/joim.12316","volume":"277","author":"N Vuilleumier","year":"2015","unstructured":"Vuilleumier N, Limacher A, Mean M et al (2015) Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism. J Intern Med 277(6):707\u2013716","journal-title":"J Intern Med"},{"issue":"24","key":"1317_CR23","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.051177","volume":"124","author":"M Lankeit","year":"2011","unstructured":"Lankeit M, Jimenez D, Kostrubiec M et al (2011) Predictive value of the high-sensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 124(24):2716\u20132724","journal-title":"Circulation"},{"issue":"6","key":"1317_CR24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.201311-2040OC","volume":"189","author":"D Jimenez","year":"2014","unstructured":"Jimenez D, Kopecna D, Tapson V, On Behalf Of The Protect Investigators et al (2014) Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 189(6):718\u2013726","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1317_CR25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.thromres.2013.08.012","volume":"132","author":"S Piran","year":"2013","unstructured":"Piran S, Le Gal G, Wells PS et al (2013) Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res 132(5):515\u2013519","journal-title":"Thromb Res"},{"issue":"2 Suppl","key":"1317_CR26","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","volume":"141","author":"DA Garcia","year":"2012","unstructured":"Garcia DA, Baglin TP, Weitz JI, Samama MM, American College of Chest Physicians (2012) Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e24S\u2013e43S","journal-title":"Chest"},{"issue":"5","key":"1317_CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.163.5.621","volume":"163","author":"EM Hylek","year":"2003","unstructured":"Hylek EM, Regan S, Henault LE et al (2003) Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis. Arch Intern Med 163(5):621\u2013627","journal-title":"Arch Intern Med"},{"issue":"8","key":"1317_CR28","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","volume":"106","author":"N Martel","year":"2005","unstructured":"Martel N, Lee J, Wells PS (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106(8):2710\u20132715","journal-title":"Blood"},{"issue":"2 Suppl","key":"1317_CR29","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","volume":"141","author":"LA Linkins","year":"2012","unstructured":"Linkins LA, Dans AL, Moores LK et al (2012) Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e495S\u2013e530S","journal-title":"Chest"},{"issue":"2 Suppl","key":"1317_CR30","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","volume":"141","author":"A Holbrook","year":"2012","unstructured":"Holbrook A, Schulman S, Witt DM et al (2012) Evidence-based management of anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e152S\u2013e184S","journal-title":"Chest"},{"issue":"7","key":"1317_CR31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood-2014-03-563056","volume":"124","author":"CH Yeh","year":"2014","unstructured":"Yeh CH, Gross PL, Weitz JI (2014) Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood 124(7):1020\u20131028","journal-title":"Blood"},{"issue":"6","key":"1317_CR32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1055\/s-0038-1649953","volume":"74","author":"R Verhaeghe","year":"1995","unstructured":"Verhaeghe R (1995) Iliac vein compression as an anatomical cause of thrombophilia: Cockett\u2019s syndrome revisited. Thromb Haemost 74(6):1398\u20131401","journal-title":"Thromb Haemost"},{"issue":"7","key":"1317_CR33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.avsg.2013.05.001","volume":"27","author":"AY Mousa","year":"2013","unstructured":"Mousa AY, AbuRahma AF (2013) May-Thurner syndrome: update and review. Ann Vasc Surg 27(7):984\u2013995","journal-title":"Ann Vasc Surg"},{"issue":"24","key":"1317_CR34","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","volume":"361","author":"S Schulman","year":"2009","unstructured":"Schulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361(24):2342\u20132352","journal-title":"N Engl J Med"},{"issue":"7","key":"1317_CR35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","volume":"129","author":"S Schulman","year":"2014","unstructured":"Schulman S, Kakkar AK, Goldhaber SZ et al (2014) Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 129(7):764\u2013772","journal-title":"Circulation"},{"issue":"5","key":"1317_CR36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2011.1666","volume":"172","author":"K Uchino","year":"2012","unstructured":"Uchino K, Hernandez AV (2012) Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med 172(5):397\u2013402","journal-title":"Arch Intern Med"},{"issue":"2","key":"1317_CR37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","volume":"131","author":"DJ Graham","year":"2015","unstructured":"Graham DJ, Reichman ME, Wernecke M et al (2015) Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation 131(2):157\u2013164","journal-title":"Circulation"},{"issue":"15","key":"1317_CR38","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","volume":"124","author":"C Chai-Adisaksopha","year":"2014","unstructured":"Chai-Adisaksopha C, Crowther et al (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124(15):2450\u20132458","journal-title":"Blood"},{"issue":"12","key":"1317_CR39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139\u20131151","journal-title":"N Engl J Med"},{"issue":"26","key":"1317_CR40","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"R Bauersachs","year":"2010","unstructured":"EINSTEIN Investigators, Bauersachs R, Berkowitz SD et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363(26):2499\u20132510","journal-title":"N Engl J Med"},{"issue":"14","key":"1317_CR41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"HR Buller","year":"2012","unstructured":"EINSTEIN-PE Investigators, Buller HR, Prins MH et al (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366(14):1287\u20131297","journal-title":"N Engl J Med"},{"issue":"4","key":"1317_CR42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/bcp.12376","volume":"78","author":"YK Loke","year":"2014","unstructured":"Loke YK, Pradhan S et al (2014) Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison. Br J Clin Pharmacol 78(4):707\u2013717","journal-title":"Br J Clin Pharmacol"},{"key":"1317_CR43","doi-asserted-by":"crossref","first-page":"h1857","DOI":"10.1136\/bmj.h1857","volume":"350","author":"NS Abraham","year":"2015","unstructured":"Abraham NS, Singh S, Alexander GC et al (2015) Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 350:h1857","journal-title":"BMJ"},{"issue":"9","key":"1317_CR44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A et al (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369(9):799\u2013808","journal-title":"N Engl J Med"},{"key":"1317_CR45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2012","unstructured":"Agnelli G, Buller HR, Cohen A et al (2012) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699\u2013708","journal-title":"N Engl J Med"},{"issue":"15","key":"1317_CR46","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"Hokusai-VTE Investigators","year":"2013","unstructured":"Investigators Hokusai-VTE, Buller HR, Decousus H et al (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369(15):1406\u20131415","journal-title":"N Engl J Med"},{"key":"1317_CR47","unstructured":"PREPIC 2: interruption of inferior vena cava by a retrievable filter for the prevention of recurrent pulmonary embolism : a randomised, open label study [homepage on the Internet]. http:\/\/clinicaltrials.gov"},{"issue":"5","key":"1317_CR48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2013.07.001","volume":"27","author":"A Rajasekhar","year":"2013","unstructured":"Rajasekhar A, Streiff MB (2013) Vena cava filters for management of venous thromboembolism: a clinical review. Blood Rev 27(5):225\u2013241","journal-title":"Blood Rev"},{"issue":"6","key":"1317_CR49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jvir.2014.01.019","volume":"25","author":"R Al-Hakim","year":"2014","unstructured":"Al-Hakim R, Kee ST, Olinger K et al (2014) Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques. J Vasc Interv Radiol 25(6):933\u2013939 quiz 940","journal-title":"J Vasc Interv Radiol"},{"issue":"19","key":"1317_CR50","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","volume":"172","author":"DM Witt","year":"2012","unstructured":"Witt DM, Delate T, Garcia DA et al (2012) Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 172(19):1484\u20131491","journal-title":"Arch Intern Med"},{"issue":"12","key":"1317_CR51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.0000000000000245","volume":"82","author":"D Poli","year":"2014","unstructured":"Poli D, Antonucci E, Dentali F, Italian Federation of Anticoagulation Clinics (FCSA) et al (2014) Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology 82(12):1020\u20131026","journal-title":"Neurology"},{"issue":"7","key":"1317_CR52","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.STR.0000078311.18928.16","volume":"34","author":"MH Eckman","year":"2003","unstructured":"Eckman MH, Rosand J, Knudsen KA et al (2003) Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34(7):1710\u20131716","journal-title":"Stroke"},{"issue":"12","key":"1317_CR53","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","volume":"41","author":"A Majeed","year":"2010","unstructured":"Majeed A, Kim YK, Roberts RS et al (2010) Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 41(12):2860\u20132866","journal-title":"Stroke"},{"issue":"3","key":"1317_CR54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","volume":"112","author":"PREPIC Study Group","year":"2005","unstructured":"PREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (prevention du risque d\u2019embolie pulmonaire par interruption cave) randomized study. Circulation 112(3):416\u2013422","journal-title":"Circulation"},{"issue":"6","key":"1317_CR55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1160\/TH12-05-0352","volume":"108","author":"JD Grant","year":"2012","unstructured":"Grant JD, Stevens SM, Woller SC et al (2012) Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost 108(6):1097\u20131108","journal-title":"Thromb Haemost"},{"issue":"8","key":"1317_CR56","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1538-7836.2007.02613.x","volume":"5","author":"MJ Kovacs","year":"2007","unstructured":"Kovacs MJ, Kahn SR, Rodger M et al (2007) A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study). J Thromb Haemost 5(8):1650\u20131653","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1317_CR57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.thromres.2013.08.003","volume":"132","author":"BL Limone","year":"2013","unstructured":"Limone BL, Hernandez AV, Michalak D et al (2013) Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials. Thromb Res 132(4):420\u2013426","journal-title":"Thromb Res"},{"issue":"6","key":"1317_CR58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvir.2010.02.021","volume":"21","author":"CA Owens","year":"2010","unstructured":"Owens CA, Bui JT, Knuttinen MG et al (2010) Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 21(6):779\u2013787","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"1317_CR59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.6004\/jnccn.2013.0163","volume":"11","author":"MB Streiff","year":"2013","unstructured":"Streiff MB, Bockenstedt PL, Cataland SR et al (2013) Venous thromboembolic disease. J Natl Compr Canc Netw 11(11):1402\u20131429","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1317_CR60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-005-1140-1","volume":"13","author":"G Rozmus","year":"2005","unstructured":"Rozmus G, Daubert JP, Huang DT et al (2005) Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol 13(1):9\u201319","journal-title":"J Interv Card Electrophysiol"},{"issue":"11","key":"1317_CR61","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1540-8167.2004.04081.x","volume":"15","author":"CJ Rooden van","year":"2004","unstructured":"van Rooden CJ, Molhoek SG, Rosendaal FR et al (2004) Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 15(11):1258\u20131262","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"1317_CR62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/HCO.0b013e32833f028e","volume":"25","author":"BS Brooke","year":"2010","unstructured":"Brooke BS, Freischlag JA (2010) Contemporary management of thoracic outlet syndrome. Curr Opin Cardiol 25(6):535\u2013540","journal-title":"Curr Opin Cardiol"},{"key":"1317_CR63","first-page":"CD007218","volume":"11","author":"B Povlsen","year":"2014","unstructured":"Povlsen B, Hansson T, Povlsen SD (2014) Treatment for thoracic outlet syndrome. Cochrane Database Syst Rev 11:CD007218","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1317_CR64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17474086.2014.954541","volume":"7","author":"N Jasti","year":"2014","unstructured":"Jasti N, Streiff MB (2014) Prevention and treatment of thrombosis associated with central venous catheters in cancer patients. Expert Rev Hematol 7(5):599\u2013616","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"1317_CR65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.thromres.2007.10.011","volume":"122","author":"SR Kahn","year":"2008","unstructured":"Kahn SR, Shrier I, Kearon C (2008) Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 122(6):763\u2013773","journal-title":"Thromb Res"},{"issue":"9054","key":"1317_CR66","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(96)12215-7","volume":"349","author":"DP Brandjes","year":"1997","unstructured":"Brandjes DP, Buller HR, Heijboer H et al (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 349(9054):759\u2013762","journal-title":"Lancet"},{"issue":"4","key":"1317_CR67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","volume":"141","author":"P Prandoni","year":"2004","unstructured":"Prandoni P, Lensing AW, Prins MH et al (2004) Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141(4):249\u2013256","journal-title":"Ann Intern Med"},{"issue":"9920","key":"1317_CR68","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","volume":"383","author":"SR Kahn","year":"2014","unstructured":"Kahn SR, Shapiro S, Wells PS et al (2014) Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383(9920):880\u2013888","journal-title":"Lancet"},{"issue":"6","key":"1317_CR69","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1160\/TH14-05-0430","volume":"112","author":"SR Kahn","year":"1969","unstructured":"Kahn SR, Shapiro S, Ducruet T et al (1969) Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost 112(6):1137\u20131141","journal-title":"Thromb Haemost"},{"issue":"7614","key":"1317_CR70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(69)90002-6","volume":"2","author":"VV Kakkar","year":"1969","unstructured":"Kakkar VV, Howe CT, Flanc C, Clarke MB (1969) Natural history of postoperative deep-vein thrombosis. Lancet 2(7614):230\u2013232","journal-title":"Lancet"},{"issue":"10","key":"1317_CR71","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/archinte.1988.00380100029007","volume":"148","author":"JT Philbrick","year":"1988","unstructured":"Philbrick JT, Becker DM (1988) Calf deep venous thrombosis. A wolf in sheep\u2019s clothing? Arch Intern Med 148(10):2131\u20132138","journal-title":"Arch Intern Med"},{"issue":"3","key":"1317_CR72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1067\/mva.2003.149","volume":"37","author":"PS Macdonald","year":"2003","unstructured":"Macdonald PS, Kahn SR, Miller N, Obrand D (2003) Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 37(3):523\u2013527","journal-title":"J Vasc Surg"},{"issue":"5","key":"1317_CR73","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1160\/TH10-06-0351","volume":"104","author":"G Palareti","year":"2010","unstructured":"Palareti G, Cosmi B, Lessiani G, Rodorigo G, Guazzaloca G, Brusi C, Valdre L, Conti E, Sartori M, Legnani C (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104(5):1063\u20131070","journal-title":"Thromb Haemost"},{"issue":"3","key":"1317_CR74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-011-0670-x","volume":"33","author":"FA Spencer","year":"2012","unstructured":"Spencer FA, Kroll A, Lessard D et al (2012) Isolated calf deep vein thrombosis in the community setting: the worcester venous thromboembolism study. J Thromb Thrombolysis 33(3):211\u2013217","journal-title":"J Thromb Thrombolysis"},{"key":"1317_CR75","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1538-7836.2009.03629.x","volume":"7","author":"JP Galanaud","year":"2009","unstructured":"Galanaud JP, Quenet S, Rivron-Guillot K et al (2009) Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis versus proximal deep-vein thrombosis in 11086 patients (RIETE registry). J Thromb Haemost 7:2028\u20132034","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1317_CR76","first-page":"493","volume":"102","author":"JP Galanaud","year":"2009","unstructured":"Galanaud JP, Sevestre-Pietri MA, Bosson JL et al (2009) Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 102(3):493\u2013500","journal-title":"Thromb Haemost"},{"issue":"8454","key":"1317_CR77","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(85)90459-3","volume":"2","author":"CI Lagerstedt","year":"1985","unstructured":"Lagerstedt CI, Olsson CG, Fagher BO et al (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2(8454):515\u2013518","journal-title":"Lancet"},{"issue":"6","key":"1317_CR78","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1378\/chest.14-0235","volume":"146","author":"D Horner","year":"2014","unstructured":"Horner D, Hogg K, Body R et al (2014) The anticoagulation of calf thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest 146(6):1468\u20131477","journal-title":"Chest"},{"issue":"20","key":"1317_CR79","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.103.20.2453","volume":"103","author":"L Pinede","year":"2001","unstructured":"Pinede L, Ninet J, Duhaut P et al (2001) Comparison of 3 and 6\u00a0months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12\u00a0weeks of therapy after isolated calf deep vein thrombosis. Circulation 103(20):2453\u20132460","journal-title":"Circulation"},{"key":"1317_CR80","doi-asserted-by":"crossref","first-page":"b4583","DOI":"10.1136\/bmj.b4583","volume":"339","author":"S Sweetland","year":"2009","unstructured":"Sweetland S, Green J, Liu B et al (2009) Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 339:b4583","journal-title":"BMJ"},{"issue":"19","key":"1317_CR81","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","volume":"170","author":"A Iorio","year":"2010","unstructured":"Iorio A, Kearon C, Filippucci E et al (2010) Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med 170(19):1710\u20131716","journal-title":"Arch Intern Med"},{"issue":"10","key":"1317_CR82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","volume":"143","author":"JA Heit","year":"2005","unstructured":"Heit JA, Kobbervig CE, James AH et al (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143(10):697\u2013706","journal-title":"Ann Intern Med"},{"issue":"4","key":"1317_CR83","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","volume":"6","author":"ER Pomp","year":"2008","unstructured":"Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ (2008) Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 6(4):632\u2013637","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1317_CR84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.seminhematol.2011.08.003","volume":"48","author":"SM Bates","year":"2011","unstructured":"Bates SM (2011) Pregnancy-associated venous thromboembolism: prevention and treatment. Semin Hematol 48(4):271\u2013284","journal-title":"Semin Hematol"},{"issue":"2 Suppl","key":"1317_CR85","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","volume":"141","author":"SM Bates","year":"2012","unstructured":"Bates SM, Greer IA, Middeldorp S et al (2012) American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e691S\u2013e736S","journal-title":"Chest"},{"issue":"20","key":"1317_CR86","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2011-04-306589","volume":"118","author":"S Middeldorp","year":"2011","unstructured":"Middeldorp S (2011) How I treat pregnancy-related venous thromboembolism. Blood 118(20):5394\u20135400","journal-title":"Blood"},{"issue":"2","key":"1317_CR87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1160\/TH08-04-0238","volume":"100","author":"RH White","year":"2008","unstructured":"White RH, Chan WS, Zhou H, Ginsberg JS (2008) Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb Haemost 100(2):246\u2013252","journal-title":"Thromb Haemost"},{"issue":"3","key":"1317_CR88","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1538-7836.2011.04186.x","volume":"9","author":"JE Roeters van Lennep","year":"2011","unstructured":"Roeters van Lennep JE, Meijer E et al (2011) Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective? J Thromb Haemost 9(3):473\u2013480","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1317_CR89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.beha.2012.07.006","volume":"25","author":"AF Jacobsen","year":"2012","unstructured":"Jacobsen AF, Sandset PM (2012) Venous thromboembolism associated with pregnancy and hormonal therapy. Best Pract Res Clin Haematol 25(3):319\u2013332","journal-title":"Best Pract Res Clin Haematol"},{"key":"1317_CR90","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","volume":"350","author":"Y Vinogradova","year":"2015","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J (2015) Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 350:h2135","journal-title":"BMJ"},{"issue":"11","key":"1317_CR91","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","volume":"10","author":"S Sweetland","year":"2012","unstructured":"Sweetland S, Beral V, Balkwill A et al (2012) Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 10(11):2277\u20132286","journal-title":"J Thromb Haemost"},{"key":"1317_CR92","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","volume":"344","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, Lokkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310. BMJ 344:e2990","journal-title":"BMJ"},{"issue":"19","key":"1317_CR93","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","volume":"293","author":"SC Christiansen","year":"2005","unstructured":"Christiansen SC, Cannegieter SC, Koster T et al (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293(19):2352\u20132361","journal-title":"JAMA"},{"issue":"10","key":"1317_CR94","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1538-7836.2006.02140.x","volume":"4","author":"M Cushman","year":"2006","unstructured":"Cushman M, Glynn RJ et al (2006) Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost 4(10):2199\u20132203","journal-title":"J Thromb Haemost"},{"issue":"5","key":"1317_CR95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jth.12528","volume":"12","author":"L Eischer","year":"2014","unstructured":"Eischer L, Eichinger S, Kyrle PA (2014) The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study. J Thromb Haemost 12(5):635\u2013640","journal-title":"J Thromb Haemost"},{"key":"1317_CR96","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","volume":"342","author":"J Douketis","year":"2011","unstructured":"Douketis J, Tosetto A, Marcucci M et al (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342:d813","journal-title":"BMJ"},{"issue":"6","key":"1317_CR97","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto A, Iorio A, Marcucci M et al (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10(6):1019\u20131025","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1317_CR98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/M14-1275","volume":"162","author":"C Kearon","year":"2015","unstructured":"Kearon C, Spencer FA, O\u2019Keeffe D et al (2015) D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med 162(1):27\u201334","journal-title":"Ann Intern Med"},{"issue":"3","key":"1317_CR99","first-page":"CD001367","volume":"3","author":"BA Hutten","year":"2000","unstructured":"Hutten BA, Prins MH (2000) Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev 3(3):CD001367","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1317_CR100","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1371\/journal.pmed.0030307","volume":"3","author":"SC Cannegieter","year":"2006","unstructured":"Cannegieter SC, Doggen CJ, van Houwelingen HC, Rosendaal FR (2006) Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med 3(8):e307","journal-title":"PLoS Med"},{"issue":"9","key":"1317_CR101","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1371\/journal.pmed.0040290","volume":"4","author":"S Kuipers","year":"2007","unstructured":"Kuipers S, Cannegieter SC, Middeldorp S et al (2007) The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organizations. PLoS Med 4(9):e290","journal-title":"PLoS Med"},{"issue":"3","key":"1317_CR102","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjh.12724","volume":"165","author":"S Kuipers","year":"2014","unstructured":"Kuipers S, Venemans A, Middeldorp S et al (2014) The risk of venous thrombosis after air travel: contribution of clinical risk factors. Br J Haematol 165(3):412\u2013413","journal-title":"Br J Haematol"},{"issue":"1","key":"1317_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000331970205300101","volume":"53","author":"MR Cesarone","year":"2002","unstructured":"Cesarone MR, Belcaro G, Nicolaides AN et al (2002) Venous thrombosis from air travel: the LONFLIT3 study\u2013prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology 53(1):1\u20136","journal-title":"Angiology"},{"issue":"1","key":"1317_CR104","first-page":"452","volume":"86","author":"JA Heit","year":"2001","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM et al (2001) The epidemiology of venous thromboembolism in the community. Thromb Haemost 86(1):452\u2013463","journal-title":"Thromb Haemost"},{"issue":"6","key":"1317_CR105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6):715\u2013722","journal-title":"JAMA"},{"issue":"3","key":"1317_CR106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","volume":"345","author":"G Agnelli","year":"2001","unstructured":"Agnelli G, Prandoni P, Santamaria MG et al (2001) Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin optimal duration Italian trial investigators. N Engl J Med 345(3):165\u2013169","journal-title":"N Engl J Med"},{"issue":"1","key":"1317_CR107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","volume":"139","author":"G Agnelli","year":"2003","unstructured":"Agnelli G, Prandoni P, Becattini C et al (2003) Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 139(1):19\u201325","journal-title":"Ann Intern Med"},{"issue":"12","key":"1317_CR108","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","volume":"340","author":"C Kearon","year":"1999","unstructured":"Kearon C, Gent M, Hirsh J et al (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340(12):901\u2013907","journal-title":"N Engl J Med"},{"issue":"1","key":"1317_CR109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","volume":"314","author":"F Couturaud","year":"2015","unstructured":"Couturaud F, Sanchez O, Pernod G et al (2015) Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial. JAMA 314(1):31\u201340","journal-title":"JAMA"},{"key":"1317_CR110","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","volume":"342","author":"F Boutitie","year":"2011","unstructured":"Boutitie F, Pinede L, Schulman S et al (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants\u2019 data from seven trials. BMJ 342:d3036","journal-title":"BMJ"},{"issue":"8","key":"1317_CR111","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","volume":"368","author":"S Schulman","year":"2013","unstructured":"Schulman S, Kearon C, Kakkar AK et al (2013) Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med 368(8):709\u2013718","journal-title":"N Engl J Med"},{"key":"1317_CR112","doi-asserted-by":"crossref","first-page":"f5133","DOI":"10.1136\/bmj.f5133","volume":"347","author":"LA Castellucci","year":"2013","unstructured":"Castellucci LA, Cameron C, Le Gal G et al (2013) Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ 347:f5133","journal-title":"BMJ"},{"issue":"7","key":"1317_CR113","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","volume":"349","author":"C Kearon","year":"2003","unstructured":"Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Extended low-intensity anticoagulation for thrombo-embolism investigators. comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349(7):631\u2013639","journal-title":"N Engl J Med"},{"issue":"9","key":"1317_CR114","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","volume":"152","author":"M Carrier","year":"2010","unstructured":"Carrier M, Le Gal G, Wells PS, Rodger MA (2010) Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 152(9):578\u2013589","journal-title":"Ann Intern Med"},{"key":"1317_CR115","first-page":"002001","volume":"10","author":"A Andras","year":"2012","unstructured":"Andras A, Sala Tenna A, Crawford F (2012) Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 10:002001","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1317_CR116","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","volume":"168","author":"TC Dahlman","year":"1993","unstructured":"Dahlman TC (1993) Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 168(4):1265\u20131270","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"1317_CR117","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","volume":"5","author":"MA Rodger","year":"2007","unstructured":"Rodger MA, Kahn SR, Cranney A et al (2007) Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost 5(8):1600\u20131606","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1317_CR118","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","volume":"87","author":"V Pettila","year":"2002","unstructured":"Pettila V, Leinonen P, Markkola A et al (2002) Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 87(2):182\u2013186","journal-title":"Thromb Haemost"},{"issue":"6","key":"1317_CR119","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1160\/TH07-06-0394","volume":"98","author":"R Shetty","year":"2007","unstructured":"Shetty R, Seddighzadeh A, Parasuraman S et al (2007) Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism. Thromb Haemost 98(6):1384\u20131386","journal-title":"Thromb Haemost"},{"issue":"2","key":"1317_CR120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2014.11.032","volume":"135","author":"R Pesavento","year":"2015","unstructured":"Pesavento R, Amitrano M, Trujillo-Santos J et al (2015) Fondaparinux in the initial and long-term treatment of venous thromboembolism. Thromb Res 135(2):311\u2013317","journal-title":"Thromb Res"},{"issue":"4","key":"1317_CR121","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00223-002-2091-5","volume":"73","author":"G Matziolis","year":"2003","unstructured":"Matziolis G, Perka C, Disch A, Zippel H (2003) Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts. Calcif Tissue Int 73(4):370\u2013379","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"1317_CR122","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/bjs.4809","volume":"92","author":"AE Handschin","year":"2005","unstructured":"Handschin AE, Trentz OA, Hoerstrup SP et al (2005) Effect of low molecular weight heparin (dalteparin) and fondaparinux (arixtra) on human osteoblasts in vitro. Br J Surg 92(2):177\u2013183","journal-title":"Br J Surg"},{"issue":"21","key":"1317_CR123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","volume":"366","author":"C Becattini","year":"2012","unstructured":"Becattini C, Agnelli G, Schenone A et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366(21):1959\u20131967","journal-title":"N Engl J Med"},{"issue":"21","key":"1317_CR124","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"TA Brighton","year":"2012","unstructured":"Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367(21):1979\u20131987","journal-title":"N Engl J Med"},{"issue":"13","key":"1317_CR125","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","volume":"130","author":"J Simes","year":"2014","unstructured":"Simes J, Becattini C, Agnelli G et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130(13):1062\u20131071","journal-title":"Circulation"},{"issue":"2 Suppl","key":"1317_CR126","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","volume":"141","author":"SM Bates","year":"2012","unstructured":"Bates SM, Jaeschke R, Stevens SM et al (2012) Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e351S\u2013e418S","journal-title":"Chest"},{"key":"1317_CR127","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2009.03324.x","volume":"7","author":"G Gal Le","year":"2009","unstructured":"Le Gal G, Kovacs MJ, Carrier M et al (2009) Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost 7:752\u2013759","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1317_CR128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9343(01)00840-3","volume":"111","author":"C Luk","year":"2001","unstructured":"Luk C, Wells PS, Anderson D, Kovacs MJ (2001) Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. Am J Med 111(4):270\u2013273","journal-title":"Am J Med"},{"issue":"6","key":"1317_CR129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jth.12955","volume":"13","author":"S Schulman","year":"2015","unstructured":"Schulman S, Zondag M, Linkins L et al (2015) Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis. J Thromb Haemost 13(6):1010\u20131018","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1317_CR130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1060028013519753","volume":"48","author":"J Thachil","year":"2014","unstructured":"Thachil J (2014) Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis. Ann Pharmacother 48(3):420\u2013424","journal-title":"Ann Pharmacother"},{"key":"1317_CR131","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","volume":"7","author":"M Carrier","year":"2009","unstructured":"Carrier M, Le Gal G, Cho R et al (2009) Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients. J Thromb Haemost 7:760\u2013765","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1317_CR132","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11239-015-1188-4","volume":"39","author":"MB Streiff","year":"2015","unstructured":"Streiff MB (2015) Predicting the risk of recurrent venous thromboembolism (VTE). J Thromb Thrombolysis 39(3):353\u2013366","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"1317_CR133","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A et al (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484\u20133488","journal-title":"Blood"},{"issue":"25","key":"1317_CR134","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","volume":"123","author":"CE Chee","year":"2014","unstructured":"Chee CE, Ashrani AA, Marks RS et al (2014) Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood 123(25):3972\u20133978","journal-title":"Blood"},{"issue":"4","key":"1317_CR135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","volume":"126","author":"ML Louzada","year":"2012","unstructured":"Louzada ML, Carrier M, Lazo-Langner A et al (2012) Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation 126(4):448\u2013454","journal-title":"Circulation"},{"issue":"15","key":"1317_CR136","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","volume":"168","author":"S Eichinger","year":"2008","unstructured":"Eichinger S, Hron G, Bialonczyk C et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168(15):1678\u20131683","journal-title":"Arch Intern Med"},{"issue":"1","key":"1317_CR137","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1160\/TH13-04-0336","volume":"111","author":"MP Donadini","year":"2014","unstructured":"Donadini MP, Ageno W, Antonucci E et al (2014) Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost 111(1):172\u2013179","journal-title":"Thromb Haemost"},{"issue":"8","key":"1317_CR138","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jth.12301","volume":"11","author":"W Ageno","year":"2013","unstructured":"Ageno W, Squizzato A, Wells PS et al (2013) The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost 11(8):1597\u20131602","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1317_CR139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","volume":"153","author":"J Douketis","year":"2010","unstructured":"Douketis J, Tosetto A, Marcucci M et al (2010) Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med 153(8):523\u2013531","journal-title":"Ann Intern Med"},{"issue":"3","key":"1317_CR140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","volume":"115","author":"B Cosmi","year":"2010","unstructured":"Cosmi B, Legnani C, Tosetto A et al (2010) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115(3):481\u2013488","journal-title":"Blood"},{"issue":"2","key":"1317_CR141","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","volume":"124","author":"G Palareti","year":"2014","unstructured":"Palareti G, Cosmi B, Legnani C et al (2014) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124(2):196\u2013203","journal-title":"Blood"},{"issue":"5","key":"1317_CR142","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1160\/TH10-08-0559","volume":"105","author":"B Cosmi","year":"2011","unstructured":"Cosmi B, Legnani C, Cini M et al (2011) D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. Thromb Haemost 105(5):837\u2013845","journal-title":"Thromb Haemost"},{"issue":"4","key":"1317_CR143","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","volume":"296","author":"G Hron","year":"2006","unstructured":"Hron G, Kollars M, Binder BR et al (2006) Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 296(4):397\u2013402","journal-title":"JAMA"},{"issue":"10","key":"1317_CR144","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","volume":"6","author":"M Besser","year":"2008","unstructured":"Besser M, Baglin C, Luddington R et al (2008) High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost 6(10):1720\u20131725","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1317_CR145","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","volume":"6","author":"A Tripodi","year":"2008","unstructured":"Tripodi A, Legnani C, Chantarangkul V et al (2008) High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 6(8):1327\u20131333","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1317_CR146","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2006.01868.x","volume":"4","author":"G Hron","year":"2006","unstructured":"Hron G, Eichinger S, Weltermann A et al (2006) Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 4(4):752\u2013756","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1317_CR147","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH07-02-0115","volume":"97","author":"PA Kyrle","year":"2007","unstructured":"Kyrle PA, Hron G, Eichinger S, Wagner O (2007) Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 97(6):880\u2013883","journal-title":"Thromb Haemost"},{"issue":"5","key":"1317_CR148","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","volume":"179","author":"MA Rodger","year":"2008","unstructured":"Rodger MA, Kahn SR, Wells PS et al (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Can Med Assoc J 179(5):417\u2013426","journal-title":"Can Med Assoc J"},{"issue":"14","key":"1317_CR149","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121(14):1630\u20131636","journal-title":"Circulation"},{"issue":"3","key":"1317_CR150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","volume":"35","author":"M Shoeb","year":"2013","unstructured":"Shoeb M, Fang MC (2013) Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 35(3):312\u2013319","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"1317_CR151","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","volume":"123","author":"C Kearon","year":"2014","unstructured":"Kearon C, Akl EA (2014) Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 123(12):1794\u20131801","journal-title":"Blood"},{"key":"1317_CR152","doi-asserted-by":"crossref","unstructured":"Wells PS, Anderson DR, Rodger M, et al. (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227\u20131235","DOI":"10.1056\/NEJMoa023153"}],"updated-by":[{"DOI":"10.1007\/s11239-016-1345-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T00:00:00Z","timestamp":1457136000000}}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1317-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T20:21:27Z","timestamp":1654114887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1317-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}